Thomas Bengt Eldered

Thomas Bengt Eldered

Fondateur chez FLERIE INVEST AB

Fortune : 127 M $ au 31/07/2026

66 ans
Health Technology
Finance
Commercial Services

Profil

Mr. Thomas Bengt Eldered is an Independent Director at Xintela AB, a Chairman at Prokarium Holdings Ltd., a Chairman at Nanologica AB, a Chairman-Supervisory Board at Amarna Therapeutics BV, a Chairman at Recipharm Fontaine SAS, a Chairman at Flerie AB, a Chairman at Recipharm Monts SAS, a Chairman at B&E Participation, Inc., a Chairman at NorthX Biologics Matfors AB, a Chairman at Trimeta LLC, a Chairman of the board at Flerie Invest AB and a Chief Executive Officer at Consort Medical GmbH.
He is on the Board of Directors at Xintela AB, Prokarium Ltd., SymCel AB, Aesica Formulation Development Ltd., Aesica Holdco Ltd., B&E Invest AB, Bohus Biotech AB /Private Group/, Bohus HoldCo AB, Buzzard Pharmaceuticals AB, Chromafora AB, Cordivest AB, Cormorant Pharmaceuticals AB, Flerie Förvaltning AB, Flerie International AB, KAHR Medical Ltd., Pingvinen Penningplacering AB, Recipharm Holdings Ltd., Sixera Pharma AB, T&M Participation AB and Zentricity Holding AB. Mr. Eldered was previously employed as a Chairman by Cobra Biologics Holding AB, a Non-Executive Chairman by Cobra Biologics Ltd., a Vice President by Recip AB, a Factory Manager by Pharmacia AB, a Chairman by B&E Participation AB, a Deputy Director by Empros Pharma AB, and a Co-Managing Director by Recipharm Verwaltungs GmbH.
He also served on the board at Toleranzia AB, Recipharm Ltd., SwedenBIO Service AB, Recipharm AB, Backsell Eldered Holding AB, Flerie Participation AB, Provell Pharmaceuticals LLC, Roar BidCo AB, SwedenBIO Service AB and Zentricity International AB. He received his graduate degree from the University of Linköping.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
FLERIE AB
67,92%
20/05/2026 58 888 047 ( 67,92% ) 127 M $ 31/07/2026

Postes actifs de Thomas Bengt Eldered

SociétésPosteDébut
NANOLOGICA AB Président 21/05/2026
XINTELA AB Directeur/Membre du Conseil 01/01/2022
FLERIE INVEST AB Fondateur 01/01/2011
Directeur/Membre du Conseil -
Directeur/Membre du Conseil 04/02/2020
Directeur/Membre du Conseil 04/02/2020
Président 20/03/2010
Président 30/04/2014
Directeur/Membre du Conseil -
░░░░░░░ ░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ -
░░░░░░░░░ ░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -

Anciens postes connus de Thomas Bengt Eldered

SociétésPosteFin
░░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░░░░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ -
░░░░░░░░░ ░░░░░░░ ░░ ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░░░
░░░░░ ░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Voir l'expérience en détail de Thomas Bengt Eldered

Formation de Thomas Bengt Eldered

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

51

Relations au 1er degré

45

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées45

Distribution Services

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Finance

Health Technology

B&E Invest AB

Health Technology

Technology Services

Health Technology

Health Technology

Finance

Process Industries

Trimeta LLC

B&E Participation, Inc.

Pingvinen Penningplacering AB

Finance

Health Technology

Health Technology

Finance

Commercial Services

Health Services

Finance

Commercial Services

Miscellaneous

Finance

Health Technology

Cordivest AB

Finance

Health Technology

Finance

  1. Bourse
  2. Insiders
  3. Thomas Bengt Eldered